Leqembi (lecanimab-irmb): What Traditional Approval Means for Early Onset Alzheimer’s Disease Treatment
by Robert C. Accetta, RPh, BCGP, FASCP, Sr. Pharmacist, HCQIP, IPRO The FDA granted traditional approval of Leqembi (lecanimab-irmb), a monoclonal antibody drug which may help reduce the progression of […]